Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Dynamics in Living Cells01:19

Protein Dynamics in Living Cells

2.1K
Different fluorescence-based techniques are used to study the protein dynamics in living cells. These techniques include FRAP, FRET, and PET.
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-guided compound prioritization strategy for virtual screening identifies putative binders for the nuclear receptor LRH-1.

bioRxiv : the preprint server for biology·2026
Same author

Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

bioRxiv : the preprint server for biology·2026
Same author

Cellular context and ligand class shape CXCR4-CCR5 heteromerization in live cells.

Research square·2026
Same author

Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative.

International journal of molecular sciences·2026
Same author

Conformational diversity and fully opening mechanism of native NMDA receptor.

Nature·2026
Same author

Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2.

Journal of medicinal chemistry·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Automated Two-dimensional Spatiotemporal Analysis of Mobile Single-molecule FRET Probes
08:26

Automated Two-dimensional Spatiotemporal Analysis of Mobile Single-molecule FRET Probes

Published on: November 23, 2021

2.6K

Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly.

Xiaojun Shi1,2, Ryan Lingerak1,3, Cameron J Herting4

  • 1Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109, USA.

Science (New York, N.Y.)
|November 16, 2023
PubMed
Summary
This summary is machine-generated.

Ephrin type-A receptor 2 (EphA2) forms multimers through distinct interactions, dictating its dual role in cancer. Understanding these EphA2 assembly mechanisms is key to targeting its oncogenic functions.

More Related Videos

In vivo Quantification of G Protein Coupled Receptor Interactions using Spectrally Resolved Two-photon Microscopy
14:26

In vivo Quantification of G Protein Coupled Receptor Interactions using Spectrally Resolved Two-photon Microscopy

Published on: January 19, 2011

13.3K
Dual-Color Fluorescence Cross-Correlation Spectroscopy to Study Protein-Protein Interaction and Protein Dynamics in Live Cells
14:12

Dual-Color Fluorescence Cross-Correlation Spectroscopy to Study Protein-Protein Interaction and Protein Dynamics in Live Cells

Published on: December 11, 2021

5.3K

Related Experiment Videos

Last Updated: Jul 11, 2025

Automated Two-dimensional Spatiotemporal Analysis of Mobile Single-molecule FRET Probes
08:26

Automated Two-dimensional Spatiotemporal Analysis of Mobile Single-molecule FRET Probes

Published on: November 23, 2021

2.6K
In vivo Quantification of G Protein Coupled Receptor Interactions using Spectrally Resolved Two-photon Microscopy
14:26

In vivo Quantification of G Protein Coupled Receptor Interactions using Spectrally Resolved Two-photon Microscopy

Published on: January 19, 2011

13.3K
Dual-Color Fluorescence Cross-Correlation Spectroscopy to Study Protein-Protein Interaction and Protein Dynamics in Live Cells
14:12

Dual-Color Fluorescence Cross-Correlation Spectroscopy to Study Protein-Protein Interaction and Protein Dynamics in Live Cells

Published on: December 11, 2021

5.3K

Area of Science:

  • Molecular and Cellular Biology
  • Cancer Research
  • Biophysics

Background:

  • Ephrin type-A receptor 2 (EphA2) is a receptor tyrosine kinase.
  • EphA2 exhibits dual signaling roles: tumor-suppressive and oncogenic.
  • Ligand-free EphA2 interactions drive its complex functions.

Purpose of the Study:

  • To elucidate the molecular interactions governing EphA2 multimerization.
  • To understand how EphA2 assembly dictates its opposing roles in cancer.

Main Methods:

  • Time-resolved, live-cell fluorescence spectroscopy.
  • Analysis of intermolecular interactions in the EphA2 ectodomain.

Main Results:

  • Identified two types of intermolecular interactions in ligand-free EphA2 ectodomain assembly.
  • Symmetric interactions mediate tumor suppression by inhibiting ERK and AKT signaling.
  • Asymmetric interactions promote oncogenic signaling, cell migration, and tumor invasiveness.

Conclusions:

  • EphA2 multimerization is driven by specific intermolecular interactions.
  • The type of EphA2 assembly dictates its function in oncogenesis.
  • Targeting EphA2 assembly offers a potential strategy for cancer therapy.